Hormesis: Decoding two sides of the same coin

Pharmaceuticals

Volumn 8, Issue 4, 2015, Pages 865-883

  Bhakta Guha, Dipita ^a   Efferth, Thomas ^b  

^a SASTRA UNIVERSITY   (India)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Biphasic; Cancer; Hormesis; Mimetics; Pathways; Stressor

Indexed keywords

CHALCONE; CURCUMIN; ENDOSTATIN; EPIGALLOCATECHIN; GENISTEIN; HEAT SHOCK PROTEIN; ISOTHIOCYANIC ACID; KAEMPFEROL; KELCH LIKE ECH ASSOCIATED PROTEIN 1; METFORMIN; MITOCHONDRIAL DNA; N ACETYLPROLYLHISTIDYLSERYLCYSTEINYLASPARAGINE AMIDE; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; ROSIGLITAZONE; SECOIRIDOID; SIRTUIN; SOMATOMEDIN C; SULFORAPHANE; THROMBOSPONDIN 1; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR NRF1;

ANTIANGIOGENIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; BIOMIMETICS; BLADDER CANCER; BREAST CANCER; CALORIC RESTRICTION; CANCER GROWTH; CELLULAR STRESS RESPONSE; COLON CANCER; DRUG CYTOTOXICITY; ENDOMETRIUM CANCER; ENDOPLASMIC RETICULUM STRESS; EPIDERMOID TUMOR; EXERCISE; HEAT SHOCK RESPONSE; HEAT STRESS; HIBERNATION; HORMESIS; HUMAN; INTRACELLULAR SIGNALING; LIVER CANCER; MALIGNANT NEOPLASTIC DISEASE; MOUTH CANCER; NEUROBLASTOMA; NONHUMAN; OXIDATIVE STRESS; PANCREAS CANCER; PHYTOCHEMISTRY; PROSTATE CANCER; REVIEW; THYROID CANCER; UNFOLDED PROTEIN RESPONSE;

EID: 84949974865     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph8040865     Document Type: Review

References (119)

1. Calabrese, E. J.; Baldwin, L. A. The frequency of U-shaped dose responses in the toxicological literature. Toxicol. Sci. Off. J. Soc. Toxicol. 2001, 62, 330-338.
2. Mattson, M. P. Awareness of hormesis will enhance future research in basic and applied neuroscience. Crit. Rev. Toxicol. 2008, 38, 633-639.
3. Calabrese, V.; Cornelius, C.; Trovato, A.; Cavallaro, M.; Mancuso, C.; Di Rienzo, L.; Condorelli, D.; de Lorenzo, A.; Calabrese, E. J. The hormetic role of dietary antioxidants in free radical-related diseases. Curr. Pharm. Des. 2010, 16, 877-883.
4. Calabrese, E. J. Nitric oxide: biphasic dose responses. Crit. Rev. Toxicol. 2001, 31, 489-501.
5. Huang, S.-S.; Zheng, R.-L. Biphasic regulation of angiogenesis by reactive oxygen species. Pharm. 2006, 61, 223-229.
6. Day, R. M.; Suzuki, Y. J. Cell proliferation, reactive oxygen and cellular glutathione. Dose-Response 2006, 3, 425-442.
7. Calabrese, E. J. Hormesis: From mainstream to therapy. J. Cell Commun. Signal. 2014, 8, 289-291.
8. Gems, D.; Partridge, L. Stress-response hormesis and aging: "that which does not kill us makes us stronger". Cell MeTable 2008, 7, 200-203.
9. Kouda, K.; Iki, M. Beneficial effects of mild stress (hormetic effects): Dietary restriction and health. J. Physiol. Anthropol. 2010, 29, 127-132.
10. Martins, I.; Galluzzi, L.; Kroemer, G. Hormesis, Cell death and aging. Aging 2011, 3, 821-828.
11. Schumacher, B. Transcription-blocking dna damage in aging: a mechanism for hormesis. BioEssays News Rev. Mol. Cell. Dev. Biol. 2009, 31, 1347-1356.
12. Halliwell, B. Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life. Plant Physiol. 2006, 141, 312-322.
13. Freiberger, J.; Coulombe, K.; Suliman, H.; Carraway, M.; Piantadosi, C. Superoxide dismutase responds to hyperoxia in rat hippocampus. J. Undersea Hyperb. Med. Soc. Inc. 2004, 31, 227-232.
14. Mach, W. J.; Thimmesch, A. R.; Pierce, J. T.; Pierce, J. D. Consequences of hyperoxia and the toxicity of oxygen in the lung. Nurs. Res. Pract. 2011, 2011, 260482, doi: 10. 1155/2011/260482.
15. Speciale, A.; Chirafisi, J.; Saija, A.; Cimino, F. Nutritional antioxidants and adaptive cell responses: an update. Curr. Mol. Med. 2011, 11, 770-789.
16. Sertel, S.; Eichhorn, T.; Plinkert, P. K.; Efferth, T. Cytotoxicity of Thymus vulgaris essential oil towards human oral cavity squamous cell carcinoma. Anticancer Res. 2011, 31, 81-87.
17. Mattson, M. P.; Cheng, A. Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci. 2006, 29, 632-639.
18. Hursting, S. D.; Smith, S. M.; Lashinger, L. M.; Harvey, A. E.; Perkins, S. N. Calories and carcinogenesis: lessons learned from 30 years of calorie restriction research. Carcinogenesis 2010, 31, 83-89.
19. Longo, V. D.; Fontana, L. Calorie restriction and cancer prevention: metabolic and molecular mechanisms. Trends Pharmacol. Sci. 2010, 31, 89-98.
20. Yamaza, H.; Komatsu, T.; Wakita, S.; Kijogi, C.; Park, S.; Hayashi, H.; Chiba, T.; Mori, R.; Furuyama, T.; Mori, N.; et al. FoxO1 is involved in the antineoplastic effect of calorie restriction. Aging Cell 2010, 9, 372-382.
21. Menendez, J. A.; Joven, J.; Aragonès, G.; Barrajón-Catalán, E.; Beltrán-Debón, R.; Borrás-Linares, I.; Camps, J.; Corominas-Faja, B.; Cufí, S.; Fernández-Arroyo, S.; et al. Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: A new family of gerosuppressant agents. Cell Cycle Georget. Tex. 2013, 12, 555-578.
22. Schulz, T. J.; Zarse, K.; Voigt, A.; Urban, N.; Birringer, M.; Ristow, M. Glucose restriction extends caenorhabditis elegans life span by inducing mitochondrial respiration and increasing oxidative stress. Cell MeTable 2007, 6, 280-293.
23. Sohal, R. S.; Orr, W. C. The redox stress hypothesis of aging. Free Radic. Biol. Med. 2012, 52, 539-555.
24. Ristow, M.; Schmeisser, K. Mitohormesis: Promoting health and lifespan by increased levels of reactive oxygen species (ROS). Dose-Response Publ. Int. Hormesis Soc. 2014, 12, 288-341.
25. Hetz, C.; Mollereau, B. Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases. Nat. Rev. Neurosci. 2014, 15, 233-249.
26. Mollereau, B.; Manié, S.; Napoletano, F. Getting the better of ER stress. J. Cell Commun. Signal. 2014, 8, 311-321.
27. Maynard, K. I. Hormesis pervasiveness and its potential implications for pharmaceutical research and development. Dose-Response Publ. Int. Hormesis Soc. 2011, 9, 377-386.
28. Mayor, A. The Poison King: The Life and Legend of Mithradates, Rome's Deadliest Enemy; Princeton University Press: Princeton, NJ, USA, 2010; p. 242.
29. Henschler, D. The origin of hormesis: Historical background and driving forces. Hum. Exp. Toxicol. 2006, 25, 347-351.
30. Calabrese, V.; Cornelius, C.; Dinkova-Kostova, A. T.; Calabrese, E. J.; Mattson, M. P. Cellular stress responses, the hormesis paradigm, and vitagenes: Novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid. Redox Signal. 2010, 13, 1763-1811.
31. Costantini, D. Oxidative Stress and Hormesis in Evolutionary Ecology and Physiology: A Marriage Between Mechanistic and Evolutionary Approaches, 1st ed.; Springer Science & Business Media: Berlin, Germany, 2014.
32. Luch, A. Molecular toxicology. In Molecular, Clinical and Environmental Toxicology; Springer Science & Business Media: Berlin, Germany, 2012; Volume 1.
33. Laughlin, R. B.; Ng, J.; Guard, H. E. Hormesis: A response to low environmental concentrations of petroleum hydrocarbons. Science 1981, 211, 705-707.
34. Stebbing, A. R. Hormesis-the stimulation of growth by low levels of inhibitors. Sci. Total Environ. 1982, 22, 213-234.
35. Sonneborn, J. S. Mimetics of hormetic agents: Stress-resistance triggers. Dose-Response Publ. Int. Hormesis Soc. 2010, 8, 97-121.
36. Calabrese, E. J. Hormetic mechanisms. Crit. Rev. Toxicol. 2013, 43, 580-606.
37. Calabrese, E. J.; Dhawan, G.; Kapoor, R.; Iavicoli, I.; Calabrese, V. Hormesis: A fundamental concept with widespread biological and biomedical applications. Gerontology 2015, doi: 10. 1159/000441520.
38. Mattson, M. P. Hormesis defined. Ageing Res. Rev. 2008, 7, 1-7.
39. Dattilo, S.; Mancuso, C.; Koverech, G.; Di Mauro, P.; Ontario, M. L.; Petralia, C. C.; Petralia, A.; Maiolino, L.; Serra, A.; Calabrese, E. J.; et al. Heat shock proteins and hormesis in the diagnosis and treatment of neurodegenerative diseases. Immun. Ageing A 2015, 12, 20, doi: 10. 1186/s12979-015-0046-8.
40. Rattan, S. I. S. Hormetic modulation of aging and longevity by mild heat stress. Dose-Response 2006, 3, 533-546.
41. Richardson, R. B. Ionizing radiation and aging: rejuvenating an old idea. Aging 2009, 1, 887-902.
42. Heber, D. Vegetables, fruits and phytoestrogens in the prevention of diseases. J. Postgrad. Med. 2004, 50, 145-149.
43. Parker, J. A.; Arango, M.; Abderrahmane, S.; Lambert, E.; Tourette, C.; Catoire, H.; Néri, C. Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat. Genet. 2005, 37, 349-350.
44. Hu, R.; Xu, C.; Shen, G.; Jain, M. R.; Khor, T. O.; Gopalkrishnan, A.; Lin, W.; Reddy, B.; Chan, J. Y.; Kong, A.-N. T. Gene expression profiles induced by cancer chemopreventive isothiocyanate sulforaphane in the liver of C57BL/6J mice and C57BL/6J/Nrf2 (-/-) mice. Cancer Lett. 2006, 243, 170-192.
45. Kim, H. J.; Lee, K. W.; Lee, H. J. Protective effects of piceatannol against beta-amyloid-induced neuronal cell death. Ann. N. Y. Acad. Sci. 2007, 1095, 473-482.
46. Wang, C.; Zhang, D.; Li, G.; Liu, J.; Tian, J.; Fu, F.; Liu, K. Neuroprotective effects of safflor yellow b on brain ischemic injury. Exp. Brain Res. 2007, 177, 533-539.
47. Nair, S.; Li, W.; Kong, A.-N. T. Natural dietary anti-cancer chemopreventive compounds: Redox-mediated differential signaling mechanisms in cytoprotection of normal cells versus cytotoxicity in tumor cells. Acta Pharmacol. Sin. 2007, 28, 459-472.
48. Juge, N.; Mithen, R. F.; Traka, M. Molecular basis for chemoprevention by sulforaphane: a comprehensive review. Cell. Mol. Life Sci. CMLS 2007, 64, 1105-1127.
49. Son, T. G.; Camandola, S.; Mattson, M. P. Hormetic dietary phytochemicals. Neuromolecular Med. 2008, 10, 236-246.
50. Park, H. G.; Han, S. I.; Oh, S. Y.; Kang, H. S. Cellular responses to mild heat stress. Cell. Mol. Life Sci. CMLS 2005, 62, 10-23.
51. Le Bourg, E.; Valenti, P.; Lucchetta, P.; Payre, F. Effects of mild heat shocks at young age on aging and longevity in Drosophila melanogaster. Biogerontology 2001, 2, 155-164.
52. Blagosklonny, M. V. Hormesis does not make sense except in the light of tor-driven aging. Aging 2011, 3, 1051-1062.
53. Moskalev, A. A.; Shaposhnikov, M. V. Pharmacological inhibition of phosphoinositide 3 and tor kinases improves survival of Drosophila melanogaster. Rejuvenation Res. 2010, 13, 246-247.
54. Selye, H. The Stress of Life. Hans Selye, M. D. New York, McGraw-Hill Book Company, Inc. 1956. $5. 95. J. Bone Jt. Surg. 1957, 39, 479-479.
55. Radak, Z.; Chung, H. Y.; Koltai, E.; Taylor, A. W.; Goto, S. Exercise, oxidative stress and hormesis. Ageing Res. Rev. 2008, 7, 34-42.
56. Gomez-Cabrera, M.-C.; Martínez, A.; Santangelo, G.; Pallardó, F. V.; Sastre, J.; Viña, J. Oxidative stress in marathon runners: interest of antioxidant supplementation. Br. J. Nutr. 2006, 96, S31-S33.
57. Mahoney, D. J.; Parise, G.; Melov, S.; Safdar, A.; Tarnopolsky, M. A. Analysis of global mrna expression in human skeletal muscle during recovery from endurance exercise. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2005, 19, 1498-1500.
58. Mancuso, C.; Pani, G.; Calabrese, V. Bilirubin: an endogenous scavenger of nitric oxide and reactive nitrogen species. Redox Rep. Commun. Free Radic. Res. 2006, 11, 207-213.
59. Cornelius, C.; Koverech, G.; Crupi, R.; di Paola, R.; Koverech, A.; Lodato, F.; Scuto, M.; Salinaro, A. T.; Cuzzocrea, S.; Calabrese, E. J.; et al. Osteoporosis and alzheimer pathology: Role of cellular stress response and hormetic redox signaling in aging and bone remodeling. Front. Pharmacol. 2014, 5, 120, doi: 10. 3389/fphar. 2014. 00120.
60. Mendes, C. S.; Levet, C.; Chatelain, G.; Dourlen, P.; Fouillet, A.; Dichtel-Danjoy, M.-L.; Gambis, A.; Ryoo, H. D.; Steller, H.; Mollereau, B. ER stress protects from retinal degeneration. EMBO J. 2009, 28, 1296-1307.
61. Mollereau, B. Establishing links between endoplasmic reticulum-mediated hormesis and cancer. Mol. Cell. Biol. 2013, 33, 2372-2374.
62. Walter, P.; Ron, D. The unfolded protein response: From stress pathway to homeostatic regulation. Science 2011, 334, 1081-1086.
63. Fouillet, A.; Levet, C.; Virgone, A.; Robin, M.; Dourlen, P.; Rieusset, J.; Belaidi, E.; Ovize, M.; Touret, M.; Nataf, S.; et al. ER stress inhibits neuronal death by promoting autophagy. Autophagy 2012, 8, 915-926.
64. Marada, S.; Stewart, D. P.; Bodeen, W. J.; Han, Y.-G.; Ogden, S. K. The unfolded protein response selectively targets active smoothened mutants. Mol. Cell. Biol. 2013, 33, 2375-2387.
65. Harman, D. Aging: A theory based on free radical and radiation chemistry. J. Gerontol. 1956, 11, 298-300.
66. Cornelius, C.; Perrotta, R.; Graziano, A.; Calabrese, E. J.; Calabrese, V. Stress responses, vitagenes and hormesis as critical determinants in aging and longevity: mitochondria as a "chi". Immun. Ageing 2013, 10, 15, doi: 10. 1186/1742-4933-10-15.
67. Hosseini, M.-J.; Shaki, F.; Ghazi-Khansari, M.; Pourahmad, J. Toxicity of arsenic (iii) on isolated liver mitochondria: a new mechanistic approach. Iran. J. Pharm. Res. IJPR 2013, 12, 121-138.
68. Schmeisser, S.; Schmeisser, K.; Weimer, S.; Groth, M.; Priebe, S.; Fazius, E.; Kuhlow, D.; Pick, D.; Einax, J. W.; Guthke, R.; et al. Mitochondrial hormesis links low-dose arsenite exposure to lifespan extension. Aging Cell 2013, 12, 508-517.
69. Kenyon, C.; Chang, J.; Gensch, E.; Rudner, A.; Tabtiang, R. A. C. elegans mutant that lives twice as long as wild type. Nature 1993, 366, 461-464.
70. Tatar, M.; Kopelman, A.; Epstein, D.; Tu, M. P.; Yin, C. M.; Garofalo, R. S. A mutant drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 2001, 292, 107-110.
71. Pawlikowska, L.; Hu, D.; Huntsman, S.; Sung, A.; Chu, C.; Chen, J.; Joyner, A. H.; Schork, N. J.; Hsueh, W.-C.; Reiner, A. P.; et al. Association of common genetic variation in the insulin/IGF1 signaling pathway with human longevity. Aging Cell 2009, 8, 460-472.
72. Bhakta-Guha, D.; Saeed, M. E. M.; Greten, H. J.; Efferth, T. Dis-organizing centrosomal clusters: Specific cancer therapy for a generic spread? Curr. Med. Chem. 2015, 22, 685-694.
73. Bray, F.; Jemal, A.; Grey, N.; Ferlay, J.; Forman, D. Global cancer transitions according to the human development index (2008-2030): A population-based study. Lancet Oncol. 2012, 13, 790-801.
74. Pearce, O. M. T.; Läubli, H.; Verhagen, A.; Secrest, P.; Zhang, J.; Varki, N. M.; Crocker, P. R.; Bui, J. D.; Varki, A. Inverse hormesis of cancer growth mediated by narrow ranges of tumor-directed antibodies. Proc. Natl. Acad. Sci. USA 2014, 111, 5998-6003.
75. Suganthi, M.; Sangeetha, G.; Gayathri, G.; Ravi Sankar, B. Biphasic dose-dependent effect of lithium chloride on survival of human hormone-dependent breast cancer cells (MCF-7). Biol. Trace Elem. Res. 2012, 150, 477-486.
76. Hine, C. M.; Mitchell, J. R. NRF2 and the phase II response in acute stress resistance induced by dietary restriction. J. Clin. Exp. Pathol. 2012, S4, 7329, doi: 10. 4172/2161-0681. S4-004.
77. Lewis, K. N.; Mele, J.; Hayes, J. D.; Buffenstein, R. Nrf2, a guardian of healthspan and gatekeeper of species longevity. Integr. Comp. Biol. 2010, 50, 829-843.
78. Tong, K. I.; Kobayashi, A.; Katsuoka, F.; Yamamoto, M. Two-site substrate recognition model for the keap1-nrf2 system: A hinge and latch mechanism. Biol. Chem. 2006, 387, 1311-1320.
79. Lau, A.; Villeneuve, N. F.; Sun, Z.; Wong, P. K.; Zhang, D. D. Dual roles of Nrf2 in cancer. Pharmacol. Res. Off. J. Ital. Pharmacol. Soc. 2008, 58, 262-270.
80. Wang, X.-J.; Sun, Z.; Villeneuve, N. F.; Zhang, S.; Zhao, F.; Li, Y.; Chen, W.; Yi, X.; Zheng, W.; Wondrak, G. T.; et al. Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2. Carcinogenesis 2008, 29, 1235-1243.
81. Pi, J.; Diwan, B. A.; Sun, Y.; Liu, J.; Qu, W.; He, Y.; Styblo, M.; Waalkes, M. P. Arsenic-induced malignant transformation of human keratinocytes: involvement of nrf2. Free Radic. Biol. Med. 2008, 45, 651-658.
82. Kansanen, E.; Kuosmanen, S. M.; Leinonen, H.; Levonen, A.-L. The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer. Redox Biol. 2013, 1, 45-49.
83. Brigelius-Flohé, R.; Flohé, L. Basic principles and emerging concepts in the redox control of transcription factors. Antioxid. Redox Signal. 2011, 15, 2335-2381.
84. Nakano, H.; Nakajima, A.; Sakon-Komazawa, S.; Piao, J.-H.; Xue, X.; Okumura, K. Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ. 2006, 13, 730-737.
85. Oellerich, M. F.; Potente, M. FOXOs and sirtuins in vascular growth, maintenance, and aging. Circ. Res. 2012, 110, 1238-1251.
86. Bosch-Presegué, L.; Vaquero, A. The dual role of sirtuins in cancer. Genes Cancer 2011, 2, 648-662.
87. Langley, E.; Pearson, M.; Faretta, M.; Bauer, U.-M.; Frye, R. A.; Minucci, S.; Pelicci, P. G.; Kouzarides, T. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 2002, 21, 2383-2396.
88. Lin, Z.; Fang, D. The roles of SIRT1 in cancer. Genes Cancer 2013, 4, 97-104.
89. Yang, Y.; Hou, H.; Haller, E. M.; Nicosia, S. V.; Bai, W. Suppression of FOXO1 activity by FHL2 through SIRT1-mediated deacetylation. EMBO J. 2005, 24, 1021-1032.
90. Doñate, F.; Parry, G. C.; Shaked, Y.; Hensley, H.; Guan, X.; Beck, I.; Tel-Tsur, Z.; Plunkett, M. L.; Manuia, M.; Shaw, D. E.; et al. Pharmacology of the novel antiangiogenic peptide ATN-161 (Ac-PHSCN-NH2): Observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth. Clin. Cancer Res. 2008, 14, 2137-2144.
91. Prabhakar, V.; Balasubramanian, R.; Sathe, P.; Murali Krishna, C.; Juvekar, A. In vitro anticancer activity of monosubstituted chalcone derivatives. Int. J. Tumor Ther. 2014, 3, 1-9.
92. Reynolds, A. R.; Hart, I. R.; Watson, A. R.; Welti, J. C.; Silva, R. G.; Robinson, S. D.; da Violante, G.; Gourlaouen, M.; Salih, M.; Jones, M. C.; et al. Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat. Med. 2009, 15, 392-400.
93. Bachmeier, B.; Nerlich, A. G.; Iancu, C. M.; Cilli, M.; Schleicher, E.; Vené, R.; Dell'Eva, R.; Jochum, M.; Albini, A.; Pfeffer, U. The chemopreventive polyphenol curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell. Physiol. Biochem. Int. J. Exp. Cell. Physiol. Biochem. Pharmacol. 2007, 19, 137-152.
94. Bayet-Robert, M.; Morvan, D. Metabolomics reveals metabolic targets and biphasic responses in breast cancer cells treated by curcumin alone and in association with docetaxel. PLoS ONE 2013, 8, e57971.
95. Celik, I.; Sürücü, O.; Dietz, C.; Heymach, J. V.; Force, J.; Höschele, I.; Becker, C. M.; Folkman, J.; Kisker, O. Therapeutic efficacy of endostatin exhibits a biphasic dose-response curve. Cancer Res. 2005, 65, 11044-11050.
96. Weinreb, O.; Amit, T.; Mandel, S.; Youdim, M. B. H. Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr. 2009, 4, 283-296.
97. El Touny, L. H.; Banerjee, P. P. Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Res. 2009, 69, 3695-3703.
98. Bao, Y.; Wang, W.; Zhou, Z.; Sun, C. Benefits and risks of the hormetic effects of dietary isothiocyanates on cancer prevention. PLoS ONE 2014, 9, e114764.
99. Oh, S. M.; Kim, Y. P.; Chung, K. H. Biphasic effects of kaempferol on the estrogenicity in human breast cancer cells. Arch. Pharm. Res. 2006, 29, 354-362.
100. Martin-Castillo, B.; Vazquez-Martin, A.; Oliveras-Ferraros, C.; Menendez, J. A. Metformin and cancer: doses, mechanisms and the dandelion and hormetic phenomena. Cell Cycle Georget. Tex. 2010, 9, 1057-1064.
101. Calabrese, E. J.; Mattson, M. P.; Calabrese, V. Resveratrol commonly displays hormesis: Occurrence and biomedical significance. Hum. Exp. Toxicol. 2010, 29, 980-1015.
102. Mukherjee, S.; Dudley, J. I.; Das, D. K. Dose-dependency of resveratrol in providing health benefits. Dose-Response 2010, 8, 478-500.
103. Panigrahy, D.; Singer, S.; Shen, L. Q.; Butterfield, C. E.; Freedman, D. A.; Chen, E. J.; Moses, M. A.; Kilroy, S.; Duensing, S.; Fletcher, C.; et al. PPARγ ligands inhibit primary tumor growth and metastasis by inhibiting angiogenesis. J. Clin. Invest. 2002, 110, 923-932.
104. Motegi, K.; Harada, K.; Ohe, G.; Jones, S. J.; Ellis, I. R.; Crouch, D. H.; Schor, S. L.; Schor, A. M. Differential involvement of tgf-beta1 in mediating the motogenic effects of tsp-1 on endothelial cells, fibroblasts and oral tumour cells. Exp. Cell Res. 2008, 314, 2323-2333.
105. Mattson, M. P.; Calabrese, E. J. Hormesis: A Revolution in Biology, Toxicology and Medicine, 1st ed.; Springer Science & Business Media: Berlin, Germany, 2009.
106. Ingram, D. K.; Zhu, M.; Mamczarz, J.; Zou, S.; Lane, M. A.; Roth, G. S.; deCabo, R. Calorie restriction mimetics: An emerging research field. Aging Cell 2006, 5, 97-108.
107. Testa, G.; Biasi, F.; Poli, G.; Chiarpotto, E. Calorie restriction and dietary restriction mimetics: A strategy for improving healthy aging and longevity. Curr. Pharm. Des. 2014, 20, 2950-2977.
108. Goukassian, D. A.; Helms, E.; van Steeg, H.; van Oostrom, C.; Bhawan, J.; Gilchrest, B. A. topical DNA oligonucleotide therapy reduces UV-induced mutations and photocarcinogenesis in hairless mice. Proc. Natl. Acad. Sci. USA 2004, 101, 3933-3938.
109. Van der Horst, A.; Tertoolen, L. G. J.; de Vries-Smits, L. M. M.; Frye, R. A.; Medema, R. H.; Burgering, B. M. T. FOXO4 is acetylated upon peroxide stress and deacetylated by the longevity protein hSir2(SIRT1). J. Biol. Chem. 2004, 279, 28873-28879.
110. Guarente, L.; Picard, F. Calorie restriction-the SIR2 connection. Cell 2005, 120, 473-482.
111. Brunmair, B.; Staniek, K.; Dörig, J.; Szöcs, Z.; Stadlbauer, K.; Marian, V.; Gras, F.; Anderwald, C.; Nohl, H.; Waldhäusl, W.; et al. Activation of PPAR-δ in isolated rat skeletal muscle switches fuel preference from glucose to fatty acids. Diabetologia 2006, 49, 2713-2722.
112. Belmadani, A.; Kumar, S.; Schipma, M.; Collins, M. A.; Neafsey, E. J. Inhibition of amyloid-β-induced neurotoxicity and apoptosis by moderate ethanol preconditioning. Neuroreport 2004, 15, 2093-2096.
113. Wang, X.; Wu, J.; Shidoji, Y.; Muto, Y.; Ohishi, N.; Yagi, K.; Ikegami, S.; Shinki, T.; Udagawa, N.; Suda, T.; et al. Effects of geranylgeranoic acid in bone: induction of osteoblast differentiation and inhibition of osteoclast formation. J. Bone Miner. Res. Off. J. Am. Soc. Bone Miner. Res. 2002, 17, 91-100.
114. Borlongan, C. V.; Wang, Y.; Su, T.-P. Delta opioid peptide (D-Ala 2, D-Leu 5) Enkephalin: Linking hibernation and neuroprotection. Front. Biosci. J. Virtual Libr. 2004, 9, 3392-3398.
115. Kwak, M. K.; Egner, P. A.; Dolan, P. M.; Ramos-Gomez, M.; Groopman, J. D.; Itoh, K.; Yamamoto, M.; Kensler, T. W. Role of phase 2 enzyme induction in chemoprotection by dithiolethiones. Mutat. Res. 2001, 480-481, 305-315.
116. Hamilton, K. L. Antioxidants and cardioprotection. Med. Sci. Sports Exerc. 2007, 39, 1544-1553.
117. Tiwari, P.; Kumar, A.; Balakrishnan, S.; Kushwaha, H. S.; Mishra, K. P. Radiation-induced micronucleus formation and dna damage in human lymphocytes and their prevention by antioxidant thiols. Mutat. Res. 2009, 676, 62-68.
118. Aoki, H.; Iwado, E.; Eller, M. S.; Kondo, Y.; Fujiwara, K.; Li, G.-Z.; Hess, K. R.; Siwak, D. R.; Sawaya, R.; Mills, G. B.; et al. Telomere 3' overhang-specific DNA oligonucleotides induce autophagy in malignant glioma cells. FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol. 2007, 21, 2918-2930.
119. Vaiserman, A. M. Hormesis, adaptive epigenetic reorganization, and implications for human health and longevity. Dose-Response 2010, 8, 16-21.